A A A

People

Dr Pascal Meier

Research Lead

Dr Pascal Meier

Contact us

The Heart Hospital
University College London Hospitals
16 – 18 Westmoreland Street
London W1G 8PH

Tel - +44 (0)20 3456 7898

Percutaneous coronary interventions

Percutaneous coronary interventions

Overview

The build-up of cholesterol-laden plaques in the coronary arteries can lead to angina, myocardial infarction, or heart failure. Percutaneous coronary intervention (PCI), commonly known as angioplasty and stenting, is one of the therapeutic procedures used to treat coronary artery disease.

At the Heart Hospital, Dr Meier’s focus is on percutaneous coronary interventions and research into future technologies in Interventional Cardiology such as new stents and drugs. He is currently leading the Yale – UCL Device Development Programme and is an associate editor for the journal “Heart”.

Key research activities

Evaluation of New Cardiovascular Devices and Therapies in Interventional Cardiology

One of Dr Meier’s key areas of focus is on the evaluation of new therapies and devices in the Interventional Cardiology arena. Dr Meier is working closely with Yale University (New Haven, CT, USA) in the Yale-UCL Collaborative to develop and test new cardiovascular devices for the future.

Coronary Collateral Circulation

The collateral circulation of the heart is a system of small inter-connecting vessels which can be regarded as ‘natural bypasses’. The aim is to find ways to therapeutically induce the growth of such collateral to reduce the burden of coronary artery disease. Researchers from UCL, University of Bern, Yale University and other international collaborators examined the role of natural bypass vessels called coronary collaterals in patients with blocked arteries. The study, published in the European Heart Journal, shows patients with lots of these vessels have a 36% reduced risk of mortality, highlighting their importance as a therapeutic target.

For an updated list of publications visit www.drpascalmeier.com